cardiovasculair risico at risk for heart and vessel disease cardiovascular risk
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Eligible patients have at least one of the following risk factors of cardiovascular risk management according to the Dutch guideline for Cardiovascular risk management: ;Aged 40-75;AND * 1 of the following criteria ;1. have a high blood pressure (* 140 mmHg) or are already treated for high blood pressure 2. have a high total cholesterol (* 6.5 mmol/l) or already treated for high cholesterol 3. have diabetes mellitus type 2 (DM2) 4. have a positive family history of CVD;AND;Not adhere to the Dutch Norm for Healthy Exercise according to a self-reported questionnaire
Exclusion criteria
Exclusion criteria: - Have participated in a program to increase their level of physical activity in the past 2 years. - Are unable to give informed consent (eg. due to cognitive impairment) - Are unable to speak, write and read Dutch - Have contra-indications to increase their physical activity level (eg. unstable angina pectoris, unstable heart failure, acute illness) - Have a terminal illness - Have severe psychiatric illness or chronic disorder(s) that seriously influence the ability to improve their psychical activity level
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is level of physical activity measured with the Personal Activity Monitor. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are sedentary behaviour, self-efficacy for physical activity, patient activation and health status (EQ-5D). Potential patient-related effect modifiers are age, body mass index, level of education, social support, anxiety and depressive symptoms, patient-provider relationship and baseline amount of minutes of physical activity. Furthermore a process evaluation will be conducted to evaluate the fidelity, dose and reach of the Activate intervention, identify barriers and facilitators for implementation, and to assess the satisfaction of participants. Data will be collected at baseline, at 3 months of follow up and at 6 months of follow up. | — |
Countries
Netherlands